Mesoblast Ltd

Mesoblast Limited, a Melbourne‑based biotech pioneer, is advancing stem‑cell therapies across cardiovascular, oncology, hematology, and orthopedics, attracting major pharma interest while navigating financial challenges and a fluctuating ASX valuati…

Explore Mesoblast Limited’s cutting‑edge regenerative therapies, its ASX stock dynamics, and future growth prospects for investors and biotech professionals.

Mesoblast Limited, a biotechnology company, has announced its financial results and operational updates, highlighting the successful FDA approval and commercial launch of its product Ryoncil, a treatment for steroid-refractory acute graft-versus-hos…